Editor's Note The Centers for Disease Control and Prevention (CDC) is sounding the alarm regarding low vaccination rates for COVID-19 and flu for all adults, as well as low RSV vaccination rates for adults 60 and older. According to the December 14 announcement, study data show anti-virals are also being…

Read More

Editor's Note Guidelines for the Centers for Disease Control (CDC) about when healthcare workers should wear N95 masks are less stringent than those from California’s Division of Occupational Safety and Health (OSHA), Medical Xpress reported on December 21. Specifically, the CDC’s advisory committee has suggested that health workers wear surgical…

Read More

Editor’s Note Seasonal flu cases are spiking across the country, according to data published December 15 from the Centers for Disease Control and Prevention (CDC).   Although the surge is nationwide, activity is highest in the southeast, south-central, and west coast regions. As a result, weekly flu hospital admissions are…

Read More

Editor's Note The Joint Commission on November 1 announced the release of the 2024 ORYX performance measure reporting requirements, which will be effective starting on January 1, 2024, for critical access hospitals and hospitals. In the new requirements, acute care hospitals and critical access hospitals must join The Joint Commission National…

Read More

Editor's Note The Million Hearts Model program—an initiative to prevent one million heart attacks and strokes within 5 years—reduced the probability of a first-time myocardial infarction or stroke without significant changes in Medicare spending. The findings were published by JAMA Network on October 12. The Million Hearts Model paid healthcare…

Read More

Editor's Note An experimental vaccine designed by researchers at University of Southern California has been shown to prevent serious infections from drug-resistant pathogens, according to an October 2023 study published by Science Translational Medicine. In this study, titled "A protein-free vaccine stimulates innate immunity and protects against nosocomial pathogens," the…

Read More

Editor's Note The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports. The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6…

Read More

Editor's Note The COVID-19 hospital admission rate in the US rose some 16% to more than 17,400 for the week ending August 26, and deaths increased by nearly 18% from the prior week, the September 7 New York Times reports. This marks the seventh consecutive week of increases. The Omicron…

Read More

Editor's Note The Centers for Disease Control and Prevention, on August 24, announced the launch of a new program to strengthen survival and recovery rates for sepsis patients, called the “Hospital Sepsis Program Core Elements.” The program is aimed at helping hospitals implement, monitor, and optimize sepsis programs and improve…

Read More

Editor's Note The COVID-19 Omicron subvariant EG.5 is now the dominant variant in the US, replacing Arcturus XBB.1.16, according to the August 4 US News & World Report. EG.5 accounts for more than 17% of new COVID-19 cases in the US in the past 2 weeks, and it is increasing…

Read More